movantik to be sold

[anonymous]

what does this mean for us

 

[anonymous]

Lies.

 

[anonymous]

Lies.

Contract reps will take it after CNS is dismantled. Good luck to everyone

 

[anonymous]

I think they will sell it to DSI

 

[anonymous]

And it is gone......

5.1.16

British drugmaker AstraZeneca has sold the European marketing rights for the opioid-induced constipation drug Moventig to ProStrakan, a unit of Japanese biopharma firm Kyowa Hakko Kirin. It is the second big sale of a non-core drug that the company has made in the last two days.

 

[anonymous]

And it is gone......

5.1.16

British drugmaker AstraZeneca has sold the European marketing rights for the opioid-induced constipation drug Moventig to ProStrakan, a unit of Japanese biopharma firm Kyowa Hakko Kirin. It is the second big sale of a non-core drug that the company has made in the last two days.

When previous Genentech -Roch reps tell you this is Pascal MO believe us , he sold off drugs and never did anything to keep or save primary care / metabolism specialist sales force. Just lead us on and soak us dry for every Ounce of work .

 

[anonymous]

old news ...they sold rights overseas but u.s. Retains selling movantik...where most of the opioids at sold

 

[anonymous]

I bet we are going to sell it, all these meetings with the CBD doing business reviews and the DSI managers want nothing to with us. Wish I would have never moved to this division

 

[anonymous]

News flash. MOST divisions are doing reviews with CBD. It happens same time every year!